Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Sometimes a needle nicks one on the way in or out, even when the injection is done correctly
A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials
Diabetes Care 44 , 13851392 (2021)
The smaller the particle size, the greater bioavailability
Two of the most powerful glutathione-boosting ingredients found in every Indian kitchen are turmeric and garlic